- Home
- STT vs CAH Comparison
STT vs CAH Comparison
Compare STT & CAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | STT | CAH |
|---|---|---|
| Founded | 1792 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Other Pharmaceuticals |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 48.1B | 55.0B |
| IPO Year | 2021 | 1994 |
Fundamental Metrics
Financial Performance| Metric | STT | CAH |
|---|---|---|
| Price | $166.35 | $247.59 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 17 |
| Target Price | $199.03 | ★ $270.47 |
| AVG Volume (30 Days) | ★ 1.8M | 1.6M |
| Earning Date | 10-14-2026 | 11-05-2026 |
| Dividend Yield | ★ 2.11% | 0.86% |
| EPS Growth | ★ 14.49 | 12.09 |
| EPS | 6.14 | ★ 7.23 |
| Revenue | $13,944,000,000.00 | ★ $254,248,000,000.00 |
| Revenue This Year | $14.54 | $4.53 |
| Revenue Next Year | $5.30 | $6.05 |
| P/E Ratio | ★ $28.33 | $33.16 |
| Revenue Growth | 7.26 | ★ 14.23 |
| 52 Week Low | $104.64 | $152.46 |
| 52 Week High | $195.93 | $258.30 |
Technical Indicators
Market Signals| Indicator | STT | CAH |
|---|---|---|
| Relative Strength Index (RSI) | 22.74 | 69.74 |
| Support Level | $164.74 | $216.88 |
| Resistance Level | $194.76 | $249.29 |
| Average True Range (ATR) | 3.53 | 5.56 |
| MACD | -0.57 | 2.27 |
| Stochastic Oscillator | 37.27 | 99.74 |
Price Performance
Historical ComparisonAbout STT State Street Corporation
State Street is a leading provider of financial services, including investment servicing, investment management, and investment research and trading. With approximately $54 trillion in assets under custody and administration, and $5.7 trillion in assets under management, as of Dec. 31, 2025, State Street operates globally in more than 100 geographic markets and employs about 51,500 worldwide.
About CAH Cardinal Health Inc.
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.